We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Model Accurately Predicts Malignancy on Breast Ultrasound

By MedImaging International staff writers
Posted on 22 Dec 2023

Artificial intelligence (AI) systems are increasingly being integrated into breast ultrasonography to potentially reduce radiologists' workload and enhance diagnostic precision. Now, a new study that evaluated an AI system's performance in BI-RADS category assessment for breast masses detected on ultrasound has found that the technology can effectively predict malignancy.

The study, conducted at Acibadem Altunizade Hospital (Istanbul, Turkey), involved the analysis of 715 masses across 530 patients. It engaged three breast imaging centers from the same institution and nine breast radiologists. Ultrasound examinations were carried out by one radiologist capturing two orthogonal views of each lesion. These images were then retrospectively examined by a second radiologist who was not privy to the patient’s clinical information. A commercially available AI system also evaluated the images. The researchers measured the level of concordance between the AI system and the radiologists, along with their diagnostic effectiveness, according to the dichotomous BI-RADS category assessment.

The study noted a moderate level of concordance between the AI model and the radiologists in differentiating benign and probably benign lesions from those deemed suspicious. The AI model ascertained that none of the lesions categorized as BI-RADS 2 were malignant, although two classified as BI-RADS 3 were confirmed malignant. The researchers highlighted that considering BI-RADS 2 lesions identified by AI as non-threatening could allow radiologists to avoid numerous unnecessary benign lesion biopsies and a significant number of follow-ups. Additionally, the AI algorithm potentially downgraded a considerable percentage of BI-RADS 3, 4, and 5 lesions to BI-RADS 2 or 3 and upgraded numerous benign or possibly benign lesions as suspicious, albeit with a low malignancy risk. The researchers concluded that AI holds promise in accurately predicting malignancy, and its integration into clinical workflows could reduce unnecessary biopsies and follow-ups, thereby enhancing sustainability in healthcare practices.

Related Links:
Acibadem Altunizade Hospital 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Computed Tomography (CT) Scanner
Aquilion Serve SP
Brachytherapy Planning System
Oncentra Brachy
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Nuclear Medicine

view channel
Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)

New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients

Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.